Arcturus Therapeutics Holdings (ARCT) ROE US GAAP (year values)

2020 2021 2022 2023 2023   LTM ? CAGR 5 years ?
ROE, % ? -18.0% -90.6% 3.46% -9.44% -10.7%   -22.7%  
Changes by years, y/y, % +82pp -73pp +94pp -13pp -1pp     -41.8%

Arcturus Therapeutics Holdings. ROE, %

Arcturus Therapeutics Holdings. ROE, changes, pp

Arcturus Therapeutics Holdings (ARCT) ROE US GAAP (quarter values)

2023Q4 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
ROE, % ? -9.44% -9.55% -39.5% -26.6% -22.7%   -22.7%
Changes by years, y/y, % -13pp -13pp -74pp -55pp -58pp    
Changes by quarters, q/q, % -45pp 0pp -30pp +13pp +4pp    

Arcturus Therapeutics Holdings. ROE, %

Arcturus Therapeutics Holdings. ROE, changes, pp

Arcturus Therapeutics Holdings. ROE, changes, pp